Skip to main content
OpenTrials
Completed

NCT Number: NCT01284933

Carotid Plaque Imaging in Acute Stroke

The purpose of this study is to determine the frequency, characteristics, and consequences of vulnerable carotid artery plaques ipsilateral to an acute ischemic stroke or TIA in the territory of the internal carotid artery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Freiburg, Germany, Freiburg im Breisgau, Baden-Wurttemberg, Germany

Loading trial locations.

About this study

Even with extensive diagnostic workup the underlying etiology remains unidentified in about 25% of patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA). Non-invasive high-resolution magnetic resonance imaging (HR-MRI) of the carotid artery allows detecting vulnerable plaques (VP) and quantifying single plaque components. The hypotheses behind this study are that i) a substantial proportion of cases of AIS and TIA within the anterior circulation and no identified cause (cryptogenic AIS or TIA) are caused by VP in the carotid artery; ii) that these patients are at a high risk of developing a recurrent stroke, TIA, or clinically silent lesions detectable by brain MRI; and iii) that VP in the carotid artery are associated with specific infarct patterns as detected by diffusion-weighted MR imaging. Finally, the investigators will search for biomarkers associated with vulnerable carotid artery plaques. Motivating this study are the following considerations: i) data on the frequency and characteristics of VP in patients with cryptogenic AIS or TIA will provide valuable insights into stroke mechanisms; ii) depending on the results this study may have implications for diagnostic decision making and provide the basis for the planning of targeted interventional studies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 49 years old
  • Acute ischemic stroke or transient ischemic attack (TIA)
  • Neurological symptoms compatible with a stroke or TIA in the anterior circulation (territory of the internal carotid artery)
  • Onset of symptoms within the last 7 days
  • 1 or more acute ischemic lesion(s) visible on MR diffusion-weighted imaging (DWI) in the territory of a single internal carotid artery
  • Presence of carotid artery plaques in the ipsilateral or contralateral carotid artery as defined by ultrasound (criteria: plaque thickness at least 2mm; located within 1cm proximal or distal to the carotid bifurcation)
  • Written informed consent

Exclusion criteria

  • Primary referral to an outside hospital (to avoid recruitment bias)
  • DWI positive lesions outside the territory of a single internal carotid artery
  • Carotid artery stenosis > 69% (North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria) ipsilateral to the stroke or TIA as defined by ultrasound (systolic peak flow velocity ≥ 300 cm/s)
  • Standard contra-indications for MRI
  • Documented allergy to MRI contrast media
  • History of radiation to the neck area
  • Renal clearance < 30 ml/minute
  • Creatinine levels > 2 times the upper limit of the standard range of the respective laboratory within the last 30 days prior to MRI
  • Surgical procedure within 24 hours preceding the MRI

Treatment and study plan

Primary outcomes

  1. Frequency and characteristics of vulnerable plaques (VP) in the carotid artery ipsilateral to an acute ischemic stroke (AIS) or TIA in the territory of the carotid artery in patients with a cryptogenic stroke

    Time frame: Baseline

    For the primary outcome, definition of a VP will be based on non-invasive high-resolution magnetic resonance imaging (MRI). We will classify plaques according to the American Heart Association - Lesion Type (AHA-LT) classification (Cai et al. Circulation 2002; Saam et al.).

    Comparisons will include:

    • a comparison of the frequency and characteristics of VP ipsilateral vs. contralateral to the AIS or TIA
    • a comparison of the frequency and characteristics of ipsilateral VP in patients with cryptogenic stroke as compared to patients with cardioembolic stroke or small vessel stroke

Secondary outcomes

  1. Pattern of acute ischemic lesions on brain MRI associated with VP in the carotid artery

    Time frame: Baseline

    The pattern of acute ischemic lesions on brain MRI associated with VP in the carotid artery will be analyzed.

  2. Recurrence rates of AIS or TIA in patients with VP in the carotid artery

    Time frame: 12, 24, 36 Months

    The recurrence rates of acute ischemic strokes or transient ischemic attacks will be evaluated at follow-up after 12, 24 and 36 months.

  3. Rate of new ischemic lesions on FLAIR MRI at 12 month follow-up in patients with VP in the carotid artery

    Time frame: 12 Months

    The rate of new ischemic lesions on FLAIR MRI will be evaluated at follow-up after 12 months.

  4. Association between VP in the carotid artery and atherosclerotic plaques in the aortic arch as determined by transoesophageal ultrasound

    Time frame: Baseline

    The association between VP in the carotid artery and atherosclerotic plaques in the aortic arch as determined by transoesophageal ultrasound will be evaluated in patients with transoesophageal ultrasound.

  5. Biomarkers associated with vulnerable carotid artery plaques

    Time frame: Baseline

    Biomarkers probably associated with vulnerable carotid artery plaques will be analyzed.

Sponsors and collaborators

Lead sponsor

Ludwig-Maximilians - University of Munich

Other

Collaborators

  • Technical University of Munich

Registry information

Acronym: CAPIAS

Important dates

Study start
2011
Primary completion
2019
Study completion
2021
First posted
Jan 27, 2011
Registry last updated
Oct 13, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.